Response of subtype-specific human breast cancer-derived cells to poly(ADP-ribose) polymerase and checkpoint kinase 1 inhibition.
about
Trial Watch: Targeting ATM-CHK2 and ATR-CHK1 pathways for anticancer therapyOvercoming Resistance of Cancer Cells to PARP-1 Inhibitors with Three Different Drug CombinationsChk1 inhibition as a novel therapeutic strategy for treating triple-negative breast and ovarian cancers.mTORC1 and DNA-PKcs as novel molecular determinants of sensitivity to Chk1 inhibitionSelective tumor killing based on specific DNA-damage response deficiencies.Discussion of PARP inhibitors in cancer therapy.Therapeutic Targeting of Poly(ADP-Ribose) Polymerase-1 (PARP1) in Cancer: Current Developments, Therapeutic Strategies, and Future Opportunities.Novel splice-switching oligonucleotide promotes BRCA1 aberrant splicing and susceptibility to PARP inhibitor action.Inhibition of the checkpoint kinase Chk1 induces DNA damage and cell death in human Leukemia and Lymphoma cells.Heterogeneous drug penetrance of veliparib and carboplatin measured in triple negative breast tumors.
P2860
Q26745686-B5560536-A715-4654-ACAD-390F825444EBQ28552235-57B6F49D-78E9-4C27-A86F-3550F1AD5B01Q34062570-977F2D0B-078F-45A6-BF92-A559FEC548D2Q35809470-082357A8-4BFA-421B-9B5E-C4B01B06F791Q37976982-885E683B-50A1-4D23-9268-F4E2E09B518FQ38163013-B8307A8B-06F2-4389-BC05-25F0286126C8Q38683171-FA07C8C4-371E-4AD5-BAE1-D516970007EAQ38725261-FC3EA99B-D34E-4995-90F7-73C390B39F7FQ38986400-AE21A662-D077-4B9D-849F-739E5CBE8BB7Q41276800-276CFF99-ADD3-40A2-8B9D-D85F0256B865
P2860
Response of subtype-specific human breast cancer-derived cells to poly(ADP-ribose) polymerase and checkpoint kinase 1 inhibition.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Response of subtype-specific h ...... heckpoint kinase 1 inhibition.
@ast
Response of subtype-specific h ...... heckpoint kinase 1 inhibition.
@en
type
label
Response of subtype-specific h ...... heckpoint kinase 1 inhibition.
@ast
Response of subtype-specific h ...... heckpoint kinase 1 inhibition.
@en
prefLabel
Response of subtype-specific h ...... heckpoint kinase 1 inhibition.
@ast
Response of subtype-specific h ...... heckpoint kinase 1 inhibition.
@en
P2093
P2860
P1433
P1476
Response of subtype-specific h ...... heckpoint kinase 1 inhibition.
@en
P2093
Hidetaka Shibata
Joshua C Saldivar
Kay Huebner
Satoshi Miuma
P2860
P304
P356
10.1111/J.1349-7006.2011.02016.X
P577
2011-07-21T00:00:00Z